|
|
|
Substance Name: Aminohippurate sodium [USP]
RN: 94-16-6
UNII: SUO3KVS1O9
InChIKey: UNZMYCAEMNVPHX-UHFFFAOYSA-M
Note
- The glycine amide of 4-aminobenzoic acid. Its sodium salt is used as a diagnostic aid to measure effective renal plasma flow (ERPF) and excretory capacity.
Molecular Formula
- C9-H10-N2-O3.Na
Molecular Weight
- 216.1711
- All
- Classifications
- Links to Resources
- Names & Synonyms
- Registry Numbers
- Formulas
- Structure Descriptors
- Toxicity
Classification Codes
- Diagnostic Aid (Renal Function Determination)
- Drug / Therapeutic Agent
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Name of Substance
- Aminohippurate sodium [USP]
Synonyms
- 4-Aminohippursaeure, natriumsalz
- Amino-hippurate-sodium
- Aminohippurate sodium
- Ammohippurate sodium
- EINECS 202-309-8
- Monosodium p-aminohippurate
- N-(4-Aminobenzoyl)glycine monosodium salt
- Natrium 4-aminohippurat
- p-Aminohippurate sodium
- p-Aminohippuric acid sodium salt
- Paraaminohippurate Injection
- Sodium p-aminohippurate
- Sodium para-aminohippurate
- UNII-SUO3KVS1O9
Systematic Names
- Glycine, N-(4-aminobenzoyl)-, monosodium salt
- Hippuric acid, p-amino-, monosodium salt
- Sodium 4-aminohippurate
Registry Numbers
CAS Registry Number
- 94-16-6
FDA UNII
- SUO3KVS1O9
System Generated Number
- 0000094166
Molecular Formulas
Molecular Formula
- C9-H10-N2-O3.Na
Molecular Formula Fragments
- C9-H10-N2-O3
- COMPONENT
- Na
Structure Descriptors
InChI
1S/C9H10N2O3.Na/c10-7-3-1-6(2-4-7)9(14)11-5-8(12)13;/h1-4H,5,10H2,(H,11,14)(H,12,13);/q;+1/p-1InChIKey
UNZMYCAEMNVPHX-UHFFFAOYSA-MSmiles
c1cc(ccc1C(=O)Toxicity
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD50 | intravenous | 4930mg/kg (4930mg/kg) | PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE LUNGS, THORAX, OR RESPIRATION: DYSPNEA BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) | Journal of Pharmacology and Experimental Therapeutics. Vol. 84, Pg. 147, 1945. |
| rat | LD50 | intravenous | 4075mg/kg (4075mg/kg) | Drugs in Japan Vol. -, Pg. 828, 1990. |